Zum Hauptinhalt springen

Naltrexon

09. April 2023 | Naltrexon

Shifting the Sociometer: Opioid Receptor Blockade Lowers Self-Esteem.

Shifting the Sociometer: Opioid Receptor Blockade Lowers Self-Esteem. Tchalova K, Beland S, Chanda ML, Levitin DJ, Bartz JA. Soc Cogn Affect Neurosci. 2023 Mar 24:nsad017. doi: 10.1093/scan/nsad017. Epub ahead of print. PMID: 3696173...

08. November 2022 | Naltrexon

The effects of naltrexone on retention in treatment and being opioid-free in opioid-dependent people: A systematic review and meta-analysis.

The effects of naltrexone on retention in treatment and being opioid-free in opioid-dependent people: A systematic review and meta-analysis. Zangiabadian M, Golmohammadi S, Nejadghaderi SA, Zahmatkesh MM, Nasiri MJ, Sadeghian M. Fron...

31. Oktober 2022 | Naltrexon

Naltrexone: Addiction Drug Shows Promise Lifting Long COVID Brain Fog, Fatigue

Naltrexone: Addiction Drug Shows Promise Lifting Long COVID Brain Fog, Fatigue (Medscape, USA, 18.10.2022) https://www.medscape.com/viewarticle/982604#vp_2

31. Oktober 2022 | Naltrexon

Repurposing low-dose naltrexone for the prevention and treatment of immunothrombosis in COVID-19.

Repurposing low-dose naltrexone for the prevention and treatment of immunothrombosis in COVID-19. Pitt B, Tate AM, Gluck D, Rosenson RS, Goonewardena SN. Eur Heart J Cardiovasc Pharmacother. 2022 Jun 8;8(4):402-405. doi: 10.1093/ehjc...

11. Oktober 2022 | Naltrexon

Impact of Impulsivity, Hyperactivity, and Inattention on Discontinuation Rate among Opioid-Dependent Patients Treated with Extended-Release Naltrexone.

Impact of Impulsivity, Hyperactivity, and Inattention on Discontinuation Rate among Opioid-Dependent Patients Treated with Extended-Release Naltrexone. Karlsson AT, Vederhus JK, Clausen T, Weimand B, Solli KK, Tanum L. Int J Environ ...

06. Oktober 2022 | Naltrexon

Molecular Basis of Inhibitory Mechanism of Naltrexone and Its Metabolites through Structural and Energetic Analyses.

Molecular Basis of Inhibitory Mechanism of Naltrexone and Its Metabolites through Structural and Energetic Analyses. Bello M. Molecules. 2022 Aug 2;27(15):4919. doi: 10.3390/molecules27154919. PMID: 35956868; PMCID: PMC9369988. http...

28. Juli 2022 | Naltrexon

Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study.

Patients’ experiences of continued treatment with extended-release naltrexone: a Norwegian qualitative study. Marciuch, A., Brenna, I.H., Weimand, B. et al. Addict Sci Clin Pract 17, 36 (2022). doi.org/10.1186/s13722-022-003...

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten